ARTICLE | Product Development
Treating the treatments
June 9, 2003 7:00 AM UTC
Lessons from ASCO
While targeted therapies were hot topics at this year's American Society of Clinical Oncology meeting, systemic cancer therapies aren't going to be usurped from their entrenched positions in treatment regimens in the foreseeable future. Thus, companies see large opportunities to develop treatments for the side effects of chemotherapy and radiation therapy, which include chemotherapy-induced nausea and vomiting (CINV) and oral mucositis. ...